Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent pharmaceutical agent primarily employed for the treatment of rheumatoid arthritis. This effective substance functions by blocking the activity of interleukin-6 (IL-6), a communication protein vital in the inflammatory process. Additionally, Actemra exhibits effectiveness